PortfoliosLab logoPortfoliosLab logo

SPDR S&P Pharmaceuticals ETF (XPH) Alternatives

SPDR S&P Pharmaceuticals ETF (XPH) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with XPH. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.

Cheapest Alternatives to XPH

XPH charges 0.35% annually. Among ETFs in the Health & Biotech Equities category, these options have the lowest expense ratios among XPH alternatives.


Best Risk-Adjusted Alternatives to XPH

Among ETFs in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.


Top Performing XPH Alternatives (YTD)

XPH alternatives from the Health & Biotech Equities category, sorted by year-to-date return.


Lowest Volatility Alternatives to XPH

XPH alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.


Lowest Drawdown Alternatives to XPH

XPH alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.


Other ETFs from State Street

Most popular State Street ETFs on PortfoliosLab, across asset classes.


Often Compared With XPH

What investors most often compare with XPH, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnInception
iShares U.S. Pharmaceuticals ETFHealth & Biotech Equities
70
2.52%
May 5, 2006XPH vs IHE
Invesco Dynamic Pharmaceuticals ETFHealth & Biotech Equities
62
-0.44%
Jun 23, 2005XPH vs PJP
Alcon Inc.
14
-4.39%
XPH vs ALC
Fidelity 500 Index FundS&P 500
46
-7.05%
Feb 17, 1988XPH vs FXAIX
Novartis AG
89
14.16%
XPH vs NVS
iShares Nasdaq Biotechnology ETFHealth & Biotech Equities
78
0.12%
Feb 5, 2001XPH vs IBB
Bristol-Myers Squibb Company
45
13.77%
XPH vs BMY
UnitedHealth Group Incorporated
12
-17.39%
XPH vs UNH
Fidelity Select Pharmaceuticals PortfolioHealth & Biotech Equities
66
-2.56%
Jun 17, 2001XPH vs FPHAX
First Trust Amex Biotechnology IndexHealth & Biotech Equities
46
-2.76%
Jun 23, 2006XPH vs FBT
iShares U.S. Medical Devices ETFHealth & Biotech Equities
3
-14.09%
May 5, 2006XPH vs IHI
First Trust Health Care AlphaDEX FundHealth & Biotech Equities
24
-3.39%
May 8, 2007XPH vs FXH
Fidelity Blue Chip Growth FundLarge Cap Growth Equities
54
-11.15%
Dec 31, 1987XPH vs FBGRX
Invesco S&P 500 Equal Weight Health Care ETFHealth & Biotech Equities, S&P 500
16
-5.02%
Nov 1, 2006XPH vs RSPH
iShares Global Healthcare ETFHealth & Biotech Equities
20
-3.96%
Nov 13, 2001XPH vs IXJ
First Trust Indxx Medical Devices ETFHealth & Biotech Equities
5
-9.41%
Jun 22, 2021XPH vs MDEV
iShares Neuroscience and Healthcare ETFHealth & Biotech Equities
82
1.98%
Aug 24, 2022XPH vs IBRN
Janus Henderson Global Life Sciences Fund Class THealth & Biotech Equities
38
-6.63%
Dec 31, 1998XPH vs JAGLX
Vanguard International High Dividend Yield ETFDividend, Foreign Large Cap Equities
93
5.51%
Feb 25, 2016XPH vs VYMI
VanEck Vectors Biotech ETFHealth & Biotech Equities
55
-0.66%
Dec 20, 2011XPH vs BBH

Compare XPH with Any Fund or Stock

Compare XPH with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


SPDR S&P Pharmaceuticals ETF